Activity

Activity ID

9753

Expires

August 2, 2025

Format Type

Enduring

CME Credit

0.75

Fee

$113

CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)

Description of CME Course

According to the CDC, atrial fibrillation (AF) is the most common type of heart arrhythmia. It is estimated that 3 – 6 million people in the US have AF and this number is expected to increase. The most common consequence of AF is thromboembolism (TE) leading to stroke. To prevent stroke in patients with AF, anticoagulation therapy is recommended but there are now many choices. Part 1 of this 2-part series discusses the risk of stroke due to AF and the 3 classes of anticoagulants available to prevent thromboembolism.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

Summarize the mechanisms and properties of warfarin and NOACs. Compare the effectiveness of NOACs to each other and to warfarin in order to make an optimal prescribing decision for each individual patient. Communicate with patients about the potential complications associated with anticoagulants, the need for dosing compliance, and the importance of close follow-up.

Keywords

Anticoagulation, NOACs, atrial fibrillation

Competencies

Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement

CME Credit Type

AMA PRA Category 1 Credit

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.